This report discusses US implantable and transdermal drug delivery systems for the years 2002 and 2007, with forecasts for 2012. Topics covered include market size, product and end-use segmentation, technology and product development, market environment, product and end-use forecasts, industry composition and leading participants. Product segments cover implantable systems (including drug-eluting coronary stents and other implantable systems) and transdermal patches (including central nervous system [CNS] patches and other transdermal patches). End-use applications include cardiovascular agents, central nervous system [CNS] agents, hormones and related agents, and other agents. This 20 page report also includes a highlights summary and a resources section.
(0 items)
